Evidence map›Paper›PMID 24982419›Full record

ArticleThe Journal of biological chemistry2014

The structure of the cytomegalovirus-encoded m04 glycoprotein, a prototypical member of the m02 family of immunoevasins.

Richard Berry, Julian P Vivian, Felix A Deuss, Gautham R Balaji, Philippa M Saunders, Jie Lin, Dene R Littler, Andrew G Brooks, Jamie Rossjohn

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Chemical shift-based methods in NMR structure determination.Progress in nuclear magnetic resonance spectroscopy
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Richard BerryFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and Richard.berry@monash.edu.
Julian P VivianFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and.
Felix A DeussFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and.
Gautham R BalajiFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and.
Philippa M Saundersthe Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia, and.
Jie Linthe Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia, and.
Dene R LittlerFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and.
Andrew G Brooksthe Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia, and.
Jamie RossjohnFrom the Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and the Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia, Jamie.rossjohn@monash.edu.
Monash University · AUPeter Doherty Institute · AUCardiff University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of CMVs to evade the immune system of the host is dependent on the expression of a wide array of glycoproteins, many of which interfere with natural killer cell function. In murine CMV, two large protein families mediate this immune-evasive function. Although it is established that the m145 family members mimic the structure of MHC-I molecules, the structure of the m02 family remains unknown. The most extensively studied m02 family member is m04, a glycoprotein that escorts newly assembled MHC-I molecules to the cell surface, presumably to avoid "missing self" recognition. Here we report the crystal structure of the m04 ectodomain, thereby providing insight into this large immunoevasin family. m04 adopted a β-sandwich immunoglobulin variable (Ig-V)-like fold, despite sharing very little sequence identity with the Ig-V superfamily. In addition to the Ig-V core, m04 possesses several unique structural features that included an unusual β-strand topology, a number of extended loops and a prominent α-helix. The m04 interior was packed by a myriad of hydrophobic residues that form distinct clusters around two conserved tryptophan residues. This hydrophobic core was well conserved throughout the m02 family, thereby indicating that murine CMV encodes a number of Ig-V-like molecules. We show that m04 binds a range of MHC-I molecules with low affinity in a peptide-independent manner. Accordingly, the structure of m04, which represents the first example of an murine CMV encoded Ig-V fold, provides a basis for understanding the structure and function of this enigmatic and large family of immunoevasins.

Indexed as

Immune EvasionAmino Acid SequenceCarrier ProteinsCrystallizationGlycoproteinsHydrophobic and Hydrophilic InteractionsModels, MolecularMolecular Sequence DataProtein BindingProtein ConformationSequence Homology, Amino AcidViral ProteinsCarrier ProteinsGlycoproteinsgp34 protein, cytomegalovirusViral ProteinsGlycoprotein StructureImmunoglobulin-like DomainImmunologyNatural Killer Cells (NK Cells)Viral Protein

Identifiers

PMID24982419
PMCPMC4156045
OpenAlexW2069274531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.